Oruka Therapeutics (ORKA) Return on Assets [ROA] (2011 - 2024)
Oruka Therapeutics (ORKA) recorded Return on Assets [ROA] of -20.41% in Q2 2024, down 5.18 percentage points from -15.23% a year earlier and down 4.31 percentage points from the prior quarter.
Oruka Therapeutics (ORKA) Return on Assets [ROA] (2011 - 2024) Analysis & Trends
For FY2023, Oruka Therapeutics reported Return on Assets [ROA] of -13.19%, up 7.05 percentage points from FY2022.
- Annual Return on Assets [ROA] has a five-year change of +69.49 percentage points (FY2018 to FY2023).
- Across earlier years, Return on Assets [ROA] came in at -20.25% in FY2022 (+16.44 pp), -36.68% in FY2021 (-3.65 pp), -33.03% in FY2020 (+38.35 pp) and -71.38% in FY2019 (+11.30 pp).
- The Q2 2024 figure is the lowest quarterly Return on Assets [ROA] since Q4 2022.
- On a year-over-year basis, Return on Assets [ROA] rose in six of the last eight quarters, with an average year-over-year change of +8.55 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 59.12 percentage points in Q3 2019, against a drop of 14.55 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -16.10% (Q1 2024), -13.86% (Q4 2023) and -13.51% (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Oruka Therapeutics | 5.24 Bn | 3.30 Bn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -20.41% |
| Mar 31, 2024 | -16.10% |
| Dec 31, 2023 | -13.86% |
| Sep 30, 2023 | -13.51% |
| Jun 30, 2023 | -15.23% |
| Mar 31, 2023 | -18.78% |
| Dec 31, 2022 | -22.53% |
| Sep 30, 2022 | -31.00% |
| Jun 30, 2022 | -33.91% |
| Mar 31, 2022 | -34.91% |
| Dec 31, 2021 | -33.57% |
| Sep 30, 2021 | -29.91% |
| Jun 30, 2021 | -23.86% |
| Mar 31, 2021 | -20.93% |
| Dec 31, 2020 | -19.02% |
| Sep 30, 2020 | -18.36% |
| Jun 30, 2020 | -52.41% |
| Mar 31, 2020 | -64.24% |
| Dec 31, 2019 | -59.31% |
| Sep 30, 2019 | -56.50% |
Oruka Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();